title: Therapeutic advances in pediatric multiple sclerosis.
authors.affiliation: Department of Neurology, Stanford University/Lucile Packard Children's Hospital, Palo Alto, CA, USA. kpv@stanford.edu
authors.forename: Keith
authors.initials: K
authors.lastname: Van Haren
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Waubant
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D002648:Child; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D012307:Risk Factors; D014808:Vitamin D Deficiency / Q000150:complications
chemical_list: D000276:Adjuvants, Immunologic; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors
keywords: FDA; Food and Drug Administration; IFN; Interferon; JC; John Cunningham; MRI; MS; Magnetic resonance imaging; Multiple sclerosis; PML; Progressive multifocal leukoencephalopathy; T helper; Th